Advanced search
Publication Cover
Renal Failure Volume 45, 2023 - Issue 1
Submit an article Journal homepage
905
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study

Glomerulosclerosis is a prognostic risk factor in patients with membranous nephropathy and non-nephrotic proteinuria

Jing Suna Department of Nephrology, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaView further author information
,
Mengfei Lia Department of Nephrology, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaView further author information
,
Qianshen Zhub Department of Nephrology, Wuhan Hospital of Traditional Chinese and Western Medicine, Wuhan, ChinaView further author information
,
Yuanyuan Jiaa Department of Nephrology, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaView further author information
,
Jia Tianc Department of Nephrology, The Fourth Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaView further author information
,
Chao Zhanga Department of Nephrology, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaView further author information
&
Xuanyi Dua Department of Nephrology, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2188088 | Received 03 Nov 2022, Accepted 02 Mar 2023, Published online: 26 Mar 2023

References

  • Xu J, Hu X, Xie J, et al. Management of membranous nephropathy in Asia. Kidney Dis. 2015;1(2):119–125.
  • Rathi M, Bhagat RL, Mukhopadhyay P, et al. Changing histologic spectrum of adult nephrotic syndrome over five decades in North India: a single center experience. Indian J Nephrol. 2014;24(2):86–91.
  • Gao S, Cui Z, Wang X, et al. Rituximab therapy for primary membranous nephropathy in a chinese cohort. Front Med. 2021;8:663–680.
  • Vaziri ND. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney Int. 2016;90(1):41–52.
  • van de Logt AE, Fresquet M, Wetzels JF, et al. The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery. Kidney Int. 2019;96(6):1292–1302.
  • Marx BE, Marx M. Prediction in idiopathic membranous nephropathy. Kidney Int. 1999;56(2):666–673.
  • Huh H, Lee H, Lee JP, et al. Factors affecting the long-term outcomes of idiopathic membranous nephropathy. BMC Nephrol. 2017;18(1):104.
  • Hladunewich MA, Troyanov S, Calafati J, et al. The natural history of the non-nephrotic membranous nephropathy patient. Clin J Am Soc Nephrol. 2009;4(9):1417–1422.
  • Dumoulin A, Hill GS, Montseny JJ, et al. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis. Am J Kidney Dis. 2003;41(1):38–48.
  • Yoshimoto K, Yokoyama H, Wada T, et al. Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy. Kidney Int. 2004;65(1):148–153.
  • Wei C, He Y, Li T, et al. Glomerulosclerosis predicts poor renal outcome in patients with idiopathic membranous nephropathy. Int Urol Nephrol. 2021;53(3):505–514.
  • Liu LS, Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. Writing group of 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39(7):579–615.
  • Levey AS, Stevens LA, Schmid CH, for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
  • Ping Z, Fu-de , et al. Increasing frequency of idiopathic membranous nephropathy in primary glomerular disease: a 10-year renal biopsy study from a single chinese nephrology Centre. Nephrology. 2015;20(8):560–566.
  • Murugapandian S, Mansour I, Hudeeb M, et al. Epidemiology of glomerular disease in Southern Arizona: review of 10-Year renal biopsy data. Medicine. 2016;95(18):e3633.
  • Li J, Cui Z, Long J, et al. Primary glomerular nephropathy among hospitalized patients in a national database in China. Nephrol Dial Transplant. 2018;33(12):2173–2181.
  • Fervenza FC. A patient with nephrotic-range proteinuria and focal global glomerulosclerosis. Clin J Am Soc Nephrol. 2013;8(11):1979–1987.
  • He HG, Wu CQ, Ye K, et al. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases. BMC Nephrol. 2019;20(1):328.
  • Li J, Chen B, Gao C, et al. Clinical and pathological features of idiopathic membranous nephropathy with focal segmental sclerosis. BMC Nephrol. 2019;20(1):467.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.